Atlas Trials

A Study to Investigate the Pharmacokinetics, Safety and Tolerability of GSK1349572 (Dolutegravir, DTG) in Healthy Japanese Subjects

Clinical trial NCT01332565 · COMPLETED

Trial details

NCT number
NCT01332565
Sponsor
ViiV Healthcare
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Infection, Human Immunodeficiency Virus
Start date
2011-04-01
Primary completion
2011-06-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.